Gabapentin 300mg: Initial Dosing and Titration
For adults without renal impairment, start gabapentin at 100-300 mg at bedtime OR 300 mg three times daily on day 1, then increase by 100-300 mg every 1-7 days as tolerated, targeting 1800-3600 mg/day in three divided doses. 1, 2
Starting Dose Options
You have two evidence-based approaches:
Option 1: Conservative Bedtime Start (Preferred for tolerability)
- Day 1: 100-300 mg at bedtime
- Day 2-7: Increase by 100-300 mg every 1-7 days as tolerated
- Target: 1800-3600 mg/day in 3 divided doses 1
Option 2: Rapid Therapeutic Start (For faster pain control)
- Day 1: 300 mg once (single dose)
- Day 2: 600 mg/day (300 mg twice daily)
- Day 3: 900 mg/day (300 mg three times daily)
- Subsequent: Titrate up to 1800 mg/day (600 mg TID) 2
Target Maintenance Doses
- Minimum effective dose: 1800 mg/day (600 mg three times daily)
- Maximum dose: 3600 mg/day (1200 mg three times daily)
- Dosing interval: Maximum 12 hours between doses 2
Critical point: Doses above 1800 mg/day show comparable efficacy but not consistently superior pain relief, though some patients may benefit from titration to 3600 mg/day 1, 2. The additional benefit beyond 1800 mg/day was not demonstrated in clinical trials for postherpetic neuralgia 2.
Titration Timeline
- Adequate trial duration: 3-8 weeks for titration PLUS 2 weeks at maximum tolerated dose 1
- Total assessment period: Can require 2 months or more for full therapeutic evaluation 1
This extended timeline is necessary because gabapentin has nonlinear pharmacokinetics due to saturable absorption, requiring careful dose escalation 1.
Managing Adverse Effects
Dizziness and somnolence are dose-dependent but transient:
- These occur most frequently at doses <1800 mg/day during initial titration (20.2% dizziness, 14.9% somnolence) 3
- Paradoxically, at ≥1800 mg/day, rates drop to 9.7% and 6.9% respectively, comparable to placebo 3
- Strategy: Start low and titrate slowly to minimize these early effects 1
Peripheral edema is the only truly dose-dependent adverse effect, occurring in 7.5% at ≥1800 mg/day vs 1.4% at <1800 mg/day 3.
Special Populations
Geriatric Patients
- Use lower starting doses and slower titration 1
- Elderly patients are more likely to have unrecognized renal impairment requiring dose adjustment 2
Patients with Normal Renal Function (CrCl ≥60 mL/min)
- No dose adjustment needed
- Can use full dosing range: 900-3600 mg/day 2
Common Pitfalls to Avoid
Underdosing: Many patients receive only 1800 mg/day when they could tolerate and benefit from higher doses up to 3600 mg/day 1
Premature discontinuation: Patients may experience early adverse effects during titration that resolve with continued use; an adequate 2-month trial is essential 1
Exceeding 12-hour dosing intervals: This compromises efficacy due to the drug's pharmacokinetics 2
Rapid titration in sensitive patients: While rapid initiation (900 mg/day immediately) is well-tolerated in most patients 4, conservative titration reduces dizziness burden 1
Assuming renal function is normal: Always verify renal function before prescribing, as gabapentin requires dose reduction even with mild renal impairment 1, 2